SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.01-2.9%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Flagrante Delictu who wrote (15711)2/23/1998 3:20:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
Here's one of the associated patents:
United States Patent
5,030,565
Niman, et. al.
Jul. 9, 1991

Polypeptide-induced monoclonal receptors to protein ligands
Inventors:
Niman; Henry L. (Carlsbad, CA); Lerner; Richard A. (La Jolla, CA).
Assignee:
Scripps Clinic and Research Foundation (La Jolla, CA).
Appl. No.:
701,954
Filed:
Feb. 15, 1985

Related U.S. Application Data
Continuation-in-part of Ser No. 1,304, Aug. 17, 1984, which is a continuation-in-part of
Ser. No. 524,084, Aug. 17, 1983, abandoned.

Intl. Cl. :
G01N 33/577
Current U.S. Cl.:
530/387.7; 422/61; 435/172.2; 435/240.27;
435/70.21; 436/548; 436/813; 530/324;
530/325; 530/326; 530/327; 530/328; 530/329;
530/387.9; 530/388.85; 530/413
Field of Search:
435/68, 172.2, 240, 70.21, 240.27; 436/548,
813; 530/387, 324-329, 413; 422/61

References Cited | [Referenced By]

U.S. Patent Documents
4,532,220
Jul., 1985
Lavi
436/813 X
4,535,058
Aug., 1985
Weinberg
436/813 X
4,699,877
Oct., 1987
Cline
435/6

Foreign Patent Documents
8403087
Aug., 1984
WO
103/52

Other References

Gentry et al., J. Biol. Chem., 258:11219-11228 (1983).

Tamura et al., Cell 34:587-596 (1983).

Arneheiter et al., Nature 294:278-380 (1981).

Gonda, T. J. et al., Molecular and Cellular Biology, 2(6), 617-624 (Jun. 1982).

Der, C. J. et al., Proc. Natl. Acad. Sci., U.S.A., 79(11), 3637-3640 (Jun. 1982).

Furth, M. E. et al., J. Virol., 43(1), 294-304 (Jul. 1982).

Chemical Abstracts, 98:103976a (Mar. 1983).

Chemical Abstracts, 99:137927w (Oct. 1983).

Young and Atassi, Immunological Communications 11(1):9-16 (Jul. 23, 1982).

Schmitz, Atassi and Atassi, Molecular Immunology 19:1699-1702 (Dec. 1982).

Sutcliffe et al., Science 219:660-666 (Feb. 11, 1983).

Bulinski, International Review of Cytology 103:281-303 (1986).

Niman et al., PNAS-U.S.A. 80:4949-4953 (1983).

Newmark News and Views, Nature 305:9 (Sept. 1983).

Baltimore, TBIS 9:137-138 (Apr. 1984).

Sutcliffe et al., Nature 287:801-805 (Oct. 1980).

Sen et al., PNAS-USA 80:1246-1250 (Mar. 1980).

Wong and Goldberg PNAS-USA 78:7412-7416 (Dec. 1981).

Papkoff et al., Cell 27:109-119 (Nov. 1981).

Papkoff et al., Cell 29:417-426 (Jun. 1982).

Tamura and Bauer, EMBO J. 1:1479-1485 (1982).

Primary Examiner: Nucker; Christine
Attorney, Agent or Firm: Lyon & Lyon

Abstract

Monoclonal receptors raised to immunogenic polypeptides whose amino acid residue sequences
correspond to sequences of oncoprotein ligands are disclosed, as are method for the production of
those receptors and products and methods that utilize them. The monoclonal receptors bind both to
the oncoprotein ligand to a portion of which the polypeptide corresponds in sequence, and to the
immunogenic polypeptide to which the receptors were raised.

31 Claims, 16 Drawing Figures
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext